Brief: Tatva Chintan Pharma Chem Dec-Quarter Consol Net Profit Rises
17/01/2022 12:06
Jan 17 (Reuters) - Tatva Chintan Pharma Chem Ltd TATV.NS :
* TATVA CHINTAN PHARMA CHEM DEC-QUARTER CONSOL NET PROFIT 228.1 MILLION RUPEES VERSUS 208.8
MILLION RUPEES YEAR AGO
* TATVA CHINTAN PHARMA CHEM DEC-QUARTER CONSOL REVENUE FROM OPERATIONS 1.05 BILLION RUPEES
VERSUS
801.1 MILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE5NLFyX
Further company coverage: TATV.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tatva Chintan Pharma Chem
See all newsIndia's Tatva Chintan Pharma Chem rises as ICICI Securities raises target price
Brief: Tatva Chintan Pharma Chem Says Sept-Quarter Consol Net Profit 214.51 Million Rupees
India's Tatva Chintan Pharma hits upper circuit as Q1 profit more than doubles
Brief: Tatva Chintan Pharma Chem Sept Quarter Consol Net Profit 99.2 Million Rupees
India's Tatva Chintan Pharma Chem soars on Q1 profit jump